This plant-based health and skincare product company credits its record-breaking success to a combination of international purchase orders for HYLA e-cigarettes from Italy, Dubai, and other places. Earlier this year, Endexx acquired HYLA US Holdco, which produces and distributes organic, all-natural, nicotine-free e-cigarette products.
Furthermore, the company's CBD pain relief products and men's skincare line have started selling on Amazon in 13 countries or regions. In the United States, these two products are available at four of the country's top eight retailers: Amazon, as well as Walgreens, Target, and CVS stores.
We exceeded our expectations in the acquisition of HYLA, generating revenue that exceeded the cash expenditure for the purchase," stated Todd Davis, the CEO, in a released statement.
We believe that HYLA's powerful distribution network, combined with our growing influence in the US retail industry, will continue to yield profits beyond this quarter and create regular opportunities for breaking records. We will continue to expand market share across all categories and anticipate exciting new updates for our three product lines in the coming quarters.
According to the company, HYLA's demand for its natural ingredients, including guarana and L-DOPA, as well as feedback on excellent experiences and varieties, has been very popular.
Endexx, through its operating division CBD Unlimited, designs and distributes all-natural CBD products derived from the cannabis plant, with THC levels below 0.1%. These products include oils, capsules, topicals, and pet products, all with a shared goal of therapeutic and pain relief benefits.
2FIRSTS will continue to track and report on this topic, with updates available on the 2FIRSTS app. Scan the QR code below to download the app.
This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.
